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Background: One challenge of systems biology is the integration of new data into the preexisting, and then
re-interpretation of the integrated data. Here we use readily available metaanalysis computational methods to integrate
new data on the transcriptomic effects of EGF in primary human epidermal keratinocytes with preexisting
transcriptomics data in keratinocytes and in EGF-treated non-epidermal cell types.
Results: We find that EGF promotes keratinocyte proliferation, attachment and motility and, surprisingly, induces
DUSPs that attenuate the EGF signal. Our metaanalysis identified overlapping effects of EGF with those of IL-1 and IFNγ,
activators of keratinocyte in inflammation and wound healing. We also identified the genes and pathways suppressed
by EGF but induced by agents promoting epidermal differentiation. Metaanalysis comparison with the EGF effects in
other cell types identified extensive similarities between responses in keratinocytes and in other epithelial cell types,
but specific differences with the EGF effects in endothelial cells, and in transformed, oncogenic epithelial cell lines.
Conclusions: This work defines the specific transcriptional effects of EGF on human epidermal keratinocytes. Our
approach can serve as a suitable paradigm for integration of new omics data into preexisting databases and re-analysis
of the integrated data sets.
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Systems biology aims to integrate different levels and
types of information to understand how biological organ-
isms function and responds to perturbations. It uses a
range of computational methods and relies extensively on
massive amounts of data provided by high throughput
methods and parallel large-scale measurements. A signifi-
cant and urgent problem of molecular systems biology is
the integration of new data into the preexisting, accumu-
lated data, and then re-interpretation of the newly inte-
grated total information. This is particularly acute in
transcriptomics, where microarrays and RNA sequencing
generate and daily append large amount of new data into
the established databanks. Individual researchers and
groups can relatively easily, although not inexpensively,
produce and submit new transcriptomics data, but areCorrespondence: Miroslav.Blumenberg@nyumc.org
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reproduction in any medium, provided the oroften stymied trying to incorporate their contributions
into the established, preexisting knowledge. Information
technology core facilities, on the other hand, while provid-
ing data storage and access to analysis programs, seldom
understand the specifics of individual investigator’s re-
search areas and such cores usually find it difficult to
customize their analysis for a particular, distinct project.
Here, we use readily available, web-based, free computa-
tional metaanalysis methods to integrate the transcriptional
consequences of treating human epidermal keratinocytes
with EGF with the related, existing transcriptomics data in
public databanks.
EGF was among the first signalling molecules isolated,
and was named for its capacity to accelerate epidermal dif-
ferentiation and eye opening in newborn mice [1]. EGF has
become a paradigm for studies of extracellular and intracel-
lular signalling [2-5]. EGF binds to its receptor, EGFR, caus-
ing receptor dimerization and consequent activation of its
cytoplasmic kinase [6]. The activated kinase initiates several
signal transduction cascades of protein phosphorylation,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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expression of many genes [7]. EGF promotes cell survival,
proliferation, chemotactic migration, and suppresses ter-
minal differentiation, inhibits apoptosis etc. [8]. EGFR is a
member of the ErbB protein family and binds several
ligands in addition to EGF, e.g., TGFα, and HB-EGF [9].
The transcriptome changes caused by EGF have not
been extensively explored in its eponymous tissue, al-
though EGF is very important in the healthy epidermal
homeostasis and in several diseases [10]. Specifically in
the epidermis, EGF is known to contribute to wound
healing, regulate barrier function, suppress terminal dif-
ferentiation, cause loss of adhesion, induce secreted pro-
teases etc. [10,11]. EGFR is over-expressed in squamous
cell carcinomas [12]. Perhaps understandably, the pub-
lished microarray analyses of the effects of EGF mainly
focused on breast cancer and glioblastoma cell lines, the
two types of cancer with EGFR-associated aetiology and
have provided valuable data on the molecular effect of
its action in several cell lines [13-15]. Detailed molecular
understanding of the EGFR kinase domain led to develop-
ment of specific inhibitors, Gefitinib, Erlotinib, Herceptin,
Cetuximab, currently used to treat breast, lung, ovarian,
prostate, head-and-neck and other cancers [8,16].
To define systematically and comprehensively the tran-
scriptional changes caused by EGF in primary human epi-
dermal keratinocytes, we treated these cells with EGF and
compared parallel treated and control cultures using Affy-
metrix microarrays. We then used metaanalysis programs
to integrate the observed changes with a large set of
already existing data on transcriptional profiling in epi-
dermal keratinocytes and with data of EGF-treated non-
epidermal cell types in GEO database. We found that EGF
affects keratinocyte proliferation, attachment and motility
and, surprisingly induces DUSPs, phosphatases that at-
tenuate the EGF signal transduction in a feed-back loop.
Metaanalysis identified specific overlapping effects of EGF
with those of IL-1 and IFNγ, which play a role in keratino-
cyte activation, inflammation and wound healing. Con-
versely, we identified the specific genes and processes
suppressed by EGF, but induced by pro-differentiation
agents. Metaanalysis comparison of EGF effects in other
cell types identified extensive similarities between the
responses in keratinocytes and in other epithelial cell
types, but differences with e.g., endothelial cells. We also
found characteristic differences with transformed, onco-
genic epithelial cell lines. Our approach can serve as a
paradigm for integration of new omics data into preexist-
ing databases and analysis of the integrated data.
Results
Early time points, 1 and 4 hrs
Approximately 520 genes were induced by 50% or more
at any of the time points, and 580 were suppressed bythe EGF treatment in human epidermal keratinocytes.
The regulated genes are listed in the Additional file 1:
Table S1. A small number of genes, 44, are both induced
and suppressed by EGF, at different time points; of these,
34 are induced early, but suppressed late and 10 have
just the opposite regulation pattern.
Intriguingly, among the most prominent induced genes
are 5 dual specificity phosphatases, DUSP-1, -2, -4, -5 and
−6 (Table 1 and Additional file 2: Table S3a, Additional
file 3: Table S4a). These enzymes de-phosphorylate, and
thereby inactivate, the kinases of the ERK pathways
[17,18]. As a result of this de-phosphorylation, the signal
transduction cascades activated by the EGF are attenuated.
Apparently, the induction of the DUSPs is one of the im-
portant feed-back mechanisms that limits the intensity
and duration of the EGF effects in keratinocytes.
As expected, EGF, being a fundamental and wide-
reaching signal, affects a fairly large number of signalling
pathways. Immediately after addition, i.e., in the first
hour, EGF suppressed production of 67 genes in the ‘sig-
nalling’ ontological category, including 3 insulin-like
growth factor binding proteins, mucins, cytokines and
their receptors as well as secreted lectins, enzymes with
signalling function, such as kallikrein peptidases, and
structural proteins with signalling function, such as cad-
herins, desmocollins and desmogleins. Presumably, their
suppression inactivates the corresponding active signal-
ling pathways, and prepares the cells for new biological
processes and reactions. At the 4 h time point, 75 signal-
ling genes are induced, again comprising a wide range of
functions and pathways. For example, proteases with sig-
nalling function, ADAM8, ADAM22, cathepsins, throm-
bospondin, coagulation factors and MMPs are induced,
but so are protease inhibitors, such as serpins, TIMP1
etc. Also induced at this time point are integrins and
components of the extracellular matrix, e.g., Laminin V
and tenascin. Particularly noteworthy is the induction of
amphiregulin and TGFα (Additional file 2: Table S3b);
both are EGFR activating ligands that can sustain or ex-
tend the initial signal by EGF [19,20].
Among the regulators of proliferation and cell cycle,
which are induced after 1 h of EGF treatment, we find
CDK7, the protein thought to serve as a direct link be-
tween the regulation of transcription and the cell cycle
[21,22]. Transcription factors including BTG2, cyclin
G2, GADDα, Jun, Jun B, v-fos etc. are also induced
(Additional file 2: Table S3c). Interestingly, regulation of
apoptosis is also one of the ontological categories
induced early after EGF treatment (Additional file 2:
Table S3d). Parenthetically, we note that the negative
regulators of apoptosis are suppressed at the 48 h time
point (see below, Additional file 3: Table S4k).
EGF strongly affects cell adhesion and motility through
induction of focal adhesion, basement membrane and




Dual specificity protein phosphatase 5 7.42E-08
MAP kinase phosphatase 5 4.38E-07




regulation of transcription from
RNA polymerase II promoter
20 4.92E-06
Cell cycle control 14 6.27E-06
regulation of apoptosis 20 2.05E-05
Rhodanese-like 5 2.06E-05
nuclear lumen 24 2.14E-05




organelle lumen 27 3.32E-05
vasculature development 11 3.44E-05
response to organic substance 18 6.09E-05
JNK cascade 6 8.69E-05
4 h UP
regulation of cell proliferation 46 4.29E-15
regulation of cell motion 22 1.30E-12
plasma membrane part 68 8.83E-12
cell adhesion 25 1.25E-10
vasculature development 22 1.97E-10
plasma membrane 91 2.71E-10
Focal adhesion 23 2.71E-10
extracellular region part 40 2.87E-10
signal 75 1.24E-09
basement membrane 12 6.78E-09
response to wounding 29 6.99E-09
Signal transduction 85 7.80E-09
integrin binding 11 9.78E-09
24 h UP
Dual specificity protein phosphatase 4 1.07E-05
Secreted 26 2.04E-05
wound healing 10 2.17E-05
angiogenesis 9 2.37E-05
ectoderm development 10 3.00E-05
disulfide bond 36 3.23E-05
EGF-like region, conserved site 11 3.30E-05
MAP kinase phosphatase 4 3.62E-05
heparin-binding 6 4.53E-05
regulation of cell migration 9 6.13E-05
Table 1 Categories over-represented among the EGF
regulated genes (Continued)
extracellular region part 19 7.79E-05
Skin 26 1.11E-04





regulation of cell proliferation 18 1.57E-04
Pathways in cancer 13 1.79E-04
48 h UP
Metallothionein 8 1.21E-12




response to protein stimulus 9 1.08E-05
peptide cross-linking 5 1.16E-04
Cajal-Retzius cell 9 2.25E-04
Chaperone 8 2.75E-04
Steroid biosynthesis 5 2.81E-04
1q21 5 3.43E-04
Kidney 26 5.22E-04




plasma membrane part 56 1.11E-09
disulfide bond 59 1.15E-08
Secreted 37 2.93E-06
calcium binding 8 5.58E-05
extracellular region part 26 5.75E-05
regulation of cell motion 11 1.41E-04
Cell adhesion 19 1.62E-04
defense response 20 2.11E-04
calcium 20 2.27E-04
Keratinocyte 8 2.57E-04
sialic acid 4 4.26E-04
disease mutation 30 4.71E-04
Cell junction protein 7 7.65E-04
response to wounding 17 8.70E-04
apical part of cell 9 9.02E-04
4 h DOWN
Ichthyosis 7 3.02E-08
epidermis development 12 2.90E-07
epithelial cell differentiation 9 1.55E-05
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Table 1 Categories over-represented among the EGF
regulated genes (Continued)
cell cycle 12 1.71E-04
Keratinocyte 7 1.95E-04
Metabolism of xenobiotics by
cytochrome P450
6 2.24E-04
epidermal cell differentiation 6 2.94E-04
Foreskin 5 4.58E-04
microsome 6 5.75E-04
S100/CaBP-9 k-type, calcium binding 4 9.73E-04
disease mutation 22 9.98E-04
24 h DOWN
Intermediate filament 7 2.11E-06
Insulin-like growth factor binding
protein, N-terminal
4 3.13E-05
disease mutation 21 6.00E-05
Thyroglobulin type-1 4 9.49E-05
Structural protein 9 1.06E-04
response to abiotic stimulus 11 1.11E-04





response to steroid hormone stimulus 8 2.17E-04
signal 30 4.98E-04
Desmosomal cadherin 3 5.82E-04




response to organic substance 33 1.73E-09
response to endogenous stimulus 24 4.75E-09
regulation of programmed cell death 34 8.33E-09
Cell cycle control 23 1.43E-08
response to steroid hormone stimulus 16 4.35E-08
negative regulation of apoptosis 21 5.63E-08
response to hormone stimulus 21 1.02E-07
apicolateral plasma membrane 11 2.74E-07
Desmosomal cadherin 5 5.95E-07
response to wounding 23 2.37E-06
acetylation 52 5.00E-06
response to extracellular stimulus 14 8.15E-06
response to glucocorticoid stimulus 9 9.28E-06
regulation of cell growth 13 1.16E-05
response to nutrient 11 1.83E-05
Selected categories from DAVID analysis are presented, sorted from the best
p-values from each set. UP denotes induced by EGF, DOWN suppressed. Count
gives the number of regulated genes in each category.
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motility are complex processes that require a large set
of coordinated protein functions; EGF affects these
processes by inducing certain genes, e.g., α-actinin,
cadherin 13, thrombin receptor, SMAD3 and SMAD7,
VEGF-A and VEGF-C (Additional file 2: Table S3b, 3e),
while suppressing others, e.g., desmocollins 1 and 2,
desmoglein 1, cadherins, etc. (Additional file 2: Table S3h).
In addition, EGF induced the expression of several pro-
teins that, when mutated, cause in Epidermolysis bullosa,
such as Integrin α2, laminin α3, (Additional file 2:
Table S3e). It is unclear at present whether EGF-targeted
treatment may be beneficial in certain Epidermolysis
bullosa patients.
To confirm the proliferative and pro-migratory effects
of EGF in human epidermal keratinocytes, we counted
the cells in EGF-treated and control cultures, and we
examined the re-epithelialization of scratches in culture
(Figure 1). As expected from previous studies and from
the results described above, the addition of EGF pro-
foundly improved both the proliferation and migration
of keratinocytes.
Importantly, EGF induces defence and wounding re-
sponse genes in keratinocytes. These include angiogenic
signalling proteins, such as VEGF-A, VEGF-C, PTK2B,
activin A receptor, cadherin 13, CD59 and CD55, pla-
cental growth factor, plasminogen activator, urokinase,
TGFα, (Additional file 2: Table S3f ). Additionally, proin-
flammatory cytokines, including IL-1b and IL-6, are
induced. The induction of defence and wounding re-
sponse genes by EGF is congruent with the known pro-
tective role of EGF during skin wound healing [19].
Curiously, certain genes in the ontological categories
of defence and wounding responses, such as fibrinogen
α, PDGF receptor, lysozyme etc., are simultaneously
suppressed by EGF (Additional file 2: Table S3g). How-
ever, in general, the function of the suppressed genes in
the defence and wounding responses ontological cat-
egories is different from the function of the induced
ones: the suppressed genes often include immune system
modulators, e.g., IL-4, and interferon-α5, as well as the
infection fighting proteins e.g., defensin b-1, lysozyme,
TLR1, S100A8, etc. The ontological category of wound-
ing response is broad and apparently EGF promotes cer-
tain aspects thereof, such as re-epithelialization and
wound closure, while repressing others, such as anti-
microbial processes and certain aspects of the immune
response.
Interestingly, many proteins known as markers of
keratinocyte differentiation are suppressed by EGF
(Additional file 2: Table S3i). These include keratins
KRT1 and KRT10, filaggrin, desmosomal proteins,
SPRR and also members of the Ca-binding, S100 family
genes.













Figure 1 EGF promotes keratinocyte proliferation and
migration. a) Cell counts in the EGF-treated and EGF-starved
cultures. The results are derived from triplicate experiments. b) The
scratch assay. The black lines mark the initial boundaries of the
scratches, the white lines the leading fronts of the migrating cells.
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Importantly, the DUSPs remain induced in the EGF-
treated keratinocytes at the late time points as well, spe-
cifically DUSP-4, -5, -6 and −7 (Additional file 3: Table
S4a). At 24 h EGF induces expression of several secretedproteins, such as proteases, including MMP1, 9 and 10,
as well as protease inhibitors, such as serpins; presum-
ably, these play a role in matrix remodelling, given that
matrix components fibronectin and laminin are also
induced (Additional file 3: Table S4b). Among the
secreted growth factors we particularly note TGFα and
HB-EGF, the EGFR ligands, feed-back extenders of the
original signal. We also note the induction of VEGF-A
and VEGF-C, two angiogenic factors (see below).
Genes promoting proliferation are induced at 24 h, in-
cluding HB-EGF and TGFα, as well as additional
secreted signals and their receptors (Additional file 3:
Table S4c). Wound healing and angiogenesis proteins
are induced, including CD73, ADAM8, DKK1, endothe-
lin receptor A, fibronectin 1, integrin α2, interferon-γ re-
ceptor 2, MMP1, 9 and 10 urokinase, urokinase
receptor, plasminogen activator and serpins-B2 and -E2,
(Additional file 3: Table S4d). Extracellular matrix struc-
tural and remodelling proteins TIMP1, annexin A2,
fibronectin 1, laminin γ2, MMPs etc. are induced after
48 h (Additional file 3: Table S4d).
Interestingly, and in contrast with the early time
points, certain keratinocyte-specific genes are induced
by EGF, including some markers of keratinocyte differ-
entiation. These include S100 calcium binding proteins,
SPRRs, involucrin, serpin-B1 etc. (Additional file 3: Table
S4e). Lipid and steroid biosynthesis enzymes, tangential
markers of epidermal differentiation, are also induced;
these include ATP citrate lyase, sterol isomerase, hydro-
xysteroid-17-β-dehydrogenase 2 and pyruvate carboxyl-
ase. Unexpectedly, 48 h after EGF addition, 8 different
metallothioneins are induced (Additional file 3: Table
S4f ); their role in keratinocytes in response to EGF is
unknown.
The ontological categories suppressed at 24 and 48 hrs
include cell cycle and apoptosis. The cell cycle regula-
tion 48 h after EGF addition continues primarily by sup-
pression of cyclins A2, B1, B2 and CDK6, although
notably, CDK inhibitors p19, p21 and p57 are also sup-
pressed (Additional file 3: Table S4k). Desmosome com-
ponents and cadherins are suppressed at 24 and 48 hrs,
as are several keratin genes (Additional file 3: Table
S4h). Unexpectedly, we find KRT16 in the suppressed
gene set; KRT16 is a known marker of proliferation and
is induced in the early times after EGF addition [23].
The suppression of these cytoskeletal proteins may play
a role in keratinocyte adhesion and locomotion.
A set of genes that respond to steroids is suppressed by
EGF at the late time points (Additional file 3: Table S4i).
This we find curious, because, as noted above, the ste-
roid biosynthesis enzymes are induced (Additional file 2:
Table S3e). Perhaps the locally produced steroids accumu-
late at an even later time point. Alternatively, these
steroid-responsive genes are suppressed specifically to
Table 2 Transcription factor binding sites over-
represented in the promoters of the EGF regulated genes
a
Name Count % PValue Benjamini FDR
1 h Up
**BACH2 65 53 5.60E-05 9.80E-03 6.86E-02
IK3 65 53 1.48E-04 1.29E-02 1.81E-01
LMO2COM 80 65 1.93E-04 1.12E-02 2.36E-01
PAX3 63 51 3.25E-04 1.42E-02 3.98E-01
TATA 74 60 3.34E-04 1.17E-02 4.10E-01
**BACH1 70 57 3.52E-04 1.03E-02 4.31E-01
CEBPB 75 61 4.51E-04 1.13E-02 5.52E-01
**AP1 80 65 4.54E-04 9.94E-03 5.56E-01
SOX5 67 54 5.35E-04 1.04E-02 6.54E-01
**NFE2 53 43 6.09E-04 1.07E-02 7.45E-01
4 h Up
**BACH2 142 63 2.35E-17 4.13E-15 2.88E-14
**AP1 172 76 3.74E-16 2.93E-14 4.11E-13
**BACH1 152 67 2.67E-15 1.56E-13 3.28E-12
IK3 127 56 1.18E-09 5.21E-08 1.45E-06
STAT 106 47 5.97E-09 2.10E-07 7.33E-06
SRY 119 52 1.19E-08 3.49E-07 1.46E-05
**NFE2 105 46 1.85E-08 4.66E-07 2.28E-05
TATA 142 63 2.52E-08 5.53E-07 3.09E-05
FOXO1 116 51 4.89E-08 9.56E-07 6.00E-05
LMO2COM 148 65 3.69E-07 6.49E-06 4.52E-04
FREAC3 115 51 7.41E-07 1.19E-05 9.09E-04
RORA2 124 55 8.78E-07 1.29E-05 1.08E-03
TAXCREB 137 60 1.30E-06 1.76E-05 1.59E-03
FOXO4 137 60 1.39E-06 1.75E-05 1.70E-03
HLF 109 48 1.70E-06 2.00E-05 2.09E-03
CHOP 124 55 2.61E-06 2.87E-05 3.20E-03
MYOD 139 61 3.76E-06 3.90E-05 4.62E-03
NFAT 110 48 3.80E-06 3.72E-05 4.67E-03
FREAC7 124 55 4.02E-06 3.72E-05 4.93E-03
HFH1 117 52 4.16E-06 3.66E-05 5.10E-03
MEF2 173 76 5.42E-06 4.54E-05 6.65E-03
MEIS1BHOXA9 127 56 6.44E-06 5.15E-05 7.90E-03
POU3F2 144 63 6.77E-06 5.18E-05 8.30E-03
FREAC4 118 52 8.04E-06 5.90E-05 9.87E-03
TST1 114 50 8.68E-06 6.11E-05 1.07E-02
CREBP1 120 53 1.05E-05 7.09E-05 1.29E-02
FOXO3 79 35 1.23E-05 8.04E-05 1.51E-02
SOX5 121 53 1.47E-05 9.26E-05 1.81E-02
HSF2 108 48 1.96E-05 1.19E-04 2.41E-02
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issue deserves further examination.
Transcription factors
The transcriptional changes in response to EGF are, pre-
sumably, effected by changes in the activity of transcrip-
tion factors (TF). To identify the putative transcription
factors responsible, we searched for TF binding sites sta-
tistically overrepresented in the regulated genes using
DAVID [24]. Interestingly, we find that the induced
genes contain an overabundance of BACH1 and BACH2
binding sites (Table 2a). Statistically, the BACH binding
sites are the most prominent ones in the regulated genes
at all time points. The BACH proteins are basic leucine
zipper transcription factors, can function both as tran-
scription activators and as transcriptional repressors and
regulate transcription of genes involved in G1/S and G2/
M phases of the cell cycle; they form heterodimers with
MafK proteins and are known to be sensitive to oxida-
tive stress [25,26]. Inhibition of BACH1 reduces UV
light-caused damage in keratinocytes, apparently
through regulating the expression of heme oxygenases
[27]. In vitro, BACHs bind to AP1/NF-E2 binding sites,
TGA(GC)TCA [28]. We note that transcriptionally func-
tional AP1 sites have been found in a large proportion of
keratinocyte differentiation marker genes [29-33]. The
expression of the individual members of the AP1 protein
family in different layers of the epidermis is controver-
sial. It is, therefore, possible that the BACH proteins per-
form functions until now attributed to the AP1 proteins.
Our results suggest that the BACH proteins play impor-
tant roles in keratinocyte proliferation and differentiation,
in particular in response to EGF.
The genes induced at early time points additionally
contain a statistical overabundance of IK3, LMO2COM,
PAX3 and SOX5 binding sites. While these results sug-
gest that these four TFs mediate the EGF response, it is
also possible that the overrepresented consensus binding
sites could be recognized by other, related transcription
factors in epidermal keratinocytes.
Much fewer TF binding sites reached statistical signifi-
cance in the promoters of suppressed genes (Table 2b).
We note that CEBPβ sites have been identified at both
early and late time point genes. CEBPβ regulates genes
involved in immune and inflammatory responses and has
been shown to bind to regulatory regions of several acute-
phase and cytokine genes [34-36]. Additionally, binding
sites for POU3F2 (a.k.a. BRN2, OCT7) appear over-
represented in the suppressed genes. This transcription
factor has not been noted in keratinocytes before (although
it is important in melanocytes and melanoma [37]).
As a final point, we note that AP1 sites are common
in the suppressed genes as well (marked with asterisks
in Table 2), although only at 48 hrs do the AP1 sites
Table 2 Transcription factor binding sites over-
represented in the promoters of the EGF regulated genes
(Continued)
LYF1 102 45 2.33E-05 1.37E-04 2.86E-02
RSRFC4 118 52 2.58E-05 1.46E-04 3.16E-02
FREAC2 88 39 2.62E-05 1.44E-04 3.21E-02
CEBPA 80 35 2.66E-05 1.42E-04 3.27E-02
IK2 83 37 2.78E-05 1.44E-04 3.41E-02
CETS1P54 72 32 3.21E-05 1.62E-04 3.94E-02
b
Term Count % PValue Benjamini FDR
1 h Down
SOX5 94 48 1.47E-03 2.28E-01 1.79E + 00
CEBPB 104 54 3.43E-03 2.61E-01 4.13E + 00
STAT 71 37 3.75E-03 1.98E-01 4.51E + 00
POU3F2 109 56 5.57E-03 2.18E-01 6.62E + 00
FOXO3 57 29 6.14E-03 1.95E-01 7.28E + 00
**AP1 107 * 2.33E-02
4 h Down
HLF 59 47 7.35E-04 1.21E-01 8.98E-01
POU3F2 77 62 3.05E-03 2.36E-01 3.68E + 00
NCX 61 49 4.17E-03 2.18E-01 5.00E + 00
TATA 70 56 6.68E-03 2.55E-01 7.90E + 00
E4BP4 58 46 8.38E-03 2.56E-01 9.82E + 00
CEBPB 71 57 8.52E-03 2.22E-01 9.96E + 00
**AP1 73 * 3.57E-02
24 h Down
**BACH2 47 48 5.35E-03 6.11E-01 6.38E + 00
**AP1 58 * 2.85E-02
48 h Down
HLF 92 45 2.37E-04 4.10E-02 2.90E-01
LMO2COM 125 62 2.59E-04 2.26E-02 3.17E-01
MEF2 151 74 3.56E-04 2.08E-02 4.36E-01
FOXJ2 136 67 3.86E-04 1.70E-02 4.74E-01
SOX9 98 48 4.04E-04 1.42E-02 4.96E-01
CEBPB 117 58 6.03E-04 1.76E-02 7.38E-01
**AP1 125 62 7.64E-04 1.91E-02 9.34E-01
TATA 114 56 8.00E-04 1.75E-02 9.78E-01
HFH3 89 44 1.44E-03 2.80E-02 1.76E + 00
IRF7 97 48 1.49E-03 2.61E-02 1.82E + 00
IRF2 89 44 1.66E-03 2.64E-02 2.02E + 00
NFAT 89 44 2.78E-03 4.03E-02 3.37E + 00
TAXCREB 111 55 3.84E-03 5.10E-02 4.61E + 00
HAND1E47 97 48 4.11E-03 5.08E-02 4.94E + 00
E4BP4 91 45 4.99E-03 5.73E-02 5.96E + 00
Table 2 Transcription factor binding sites over-
represented in the promoters of the EGF regulated genes
(Continued)
FREAC2 71 35 5.12E-03 5.52E-02 6.11E + 00
POU3F2 119 59 5.18E-03 5.26E-02 6.18E + 00
STAT1 84 41 5.88E-03 5.63E-02 6.99E + 00
a) Induced genes, b) suppressed genes. The top p-value sites are presented for
each time point. Count columns give the number of genes with the respective
binding sites, % the percentage of submitted genes that have the site, while
Benjamini and FDR (false discovery rate), represent statistical values corrected
for multiple comparisons. Note the recurrence of BACH1, BACH2, AP1 and NF-
E2 sites, marked with double asterisk, which bind to similar DNA sequences. At
4 and 24 h, in suppressed genes, the AP1 sites barely miss the statistical cut
off p-value of 0.01; they are included here nevertheless.
Blumenberg BMC Genomics 2013, 14:85 Page 7 of 20
http://www.biomedcentral.com/1471-2164/14/85reach our significance cut-off p-value better than 0.01.
Clearly, the relative contributions of BACH, AP1 and
NF-E2 transcription factors in epidermal keratinocytes,
their differentiation and their responses to EGF require
more careful, in-depth study.
Metaanalysis, part 1: Intersections of genes regulated by
EGF and by other extracellular agents in keratinocytes
We compared the lists of genes regulated by EGF with
lists of genes identified previously as regulated by extra-
cellular signals, namely Interferon-γ (IFNγ), Interleukin
1 (IL-1), Retinoic acid (RA), Ephrin As and SP600125, a
specific inhibitor of JNK [38-42]. The numbers of genes
present in each list analyzed are given in Additional file
4: Table S5. We used the Lists2Networks program for
comparisons and collected both the matrix of p-values
for overlapping of related lists, as well as Bonferoni-
corrected lists of gene ontology categories ‘biological
process’ and ‘molecular function’ [43]. We also examined
GenMAPP and KEGG pathways, KEA kinase targets,
predicted promoter sites and OMIM disease-associated
genes. The gene ontology biological process comparisons
gave the most complete and detailed results and these
will be presented here (Figure 2, Tables 3 and 4); the
other categories gave qualitatively similar, if sparser
results (not shown).
Comparing lists of EGF-regulated genes revealed very
interesting patterns: EGF, IFNγ and IL-1 induce and sup-
press related sets of genes, while EphrinAs and SP600125
have antiparallel effects: genes induced by EGF are
suppressed by EphrinAs and SP600125, and vice versa
(Figure 2). Even more intriguing is the comparison of the
EGF- and RA-regulated genes: parallel at 1 h after RA
addition, the relationship is antiparallel after 4 and 24 h
and lost after 48 hrs (Figure 2).
In comparisons of regulated genes, one finds many re-
dundant or overly general ontological categories, which
have to be parsed in order to detect the specific and im-
portant ontological categories regulated in parallel. For
example, comparing lists of EGF- and IFNγ-regulated
Figure 2 Overlaps of the lists of genes regulated by EGF with those regulated by other extracellular agents. We show overlaps with
genes regulate by Interferon-γ, IL-1, Retinoic acid, the five EphrinA proteins and the JNK inhibitor SP600125. UP denotes induced, DN suppressed
genes. The overlaps with p-value better than 10-20 are marked with gray. The downward arrows mark the high overlaps between both the
induced and the suppressed gene lists. The upward arrows mark the antiparallel overlaps, i.e., between the lists of genes that are induced by EGF,
but are suppressed by other agents, and vice versa.
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egories, such as ‘biological process,’ ‘metabolic process’
or ‘cell communication.’ However, we also find specific
categories: at early time points both EGF and IFNγ in-
duce common regulators of transcription and, import-
antly, response to stress and response to wounding.
Conversely, both EGF and IFNγ suppress keratinocyte
differentiation and epidermis development genes. An-
other set of stress response genes is suppressed in com-
mon by EGF and by IFNγ. At the later time points, 24
and 48 h, proliferation and cell cycle genes are sup-
pressed by both (Table 3a).
A somewhat different picture emerges in the compari-
sons of the EGF- and IL-1-regulated genes (Table 3b).
Like IFNγ, IL-1 induces regulators of transcription and
responses to stress and wounding. Importantly, unlikeIFNγ, IL-1 also induces sets of genes responsible for cell
motility and chemotaxis. Again distinctly from IFNγ, IL-
1 induces inhibitors of apoptosis. Similar to IFNγ, IL-1
suppresses keratinocyte differentiation and epidermis de-
velopment genes. This suppression continues in IL-1
treated keratinocytes longer than in the IFNγ-treated
ones, and is still noticeable at 48 h (Table 3b).
Using the Lists2Networks program [43] for compari-
sons of predicted transcription factor binding sites in the
promoters of regulated genes, we see again characteristic
overlaps between the genes co-regulated by EGF and
IFNγ and those co-regulated by EGF and IL-1 (Figure 3).
For example, both EGF and IFNγ activate many tran-
scription factors of the AP1 family, Fos and Jun, and the
Rel NFκB proteins after 24 h (Figure 3a). The overlap of
transcription factors targets for EGF and IL-1 is sparser
Table 3 Biological processes common in the EGF-,
Interferon-γ- and IL-1-regulated genes
a
Gene ontology: Biological process EGF1&4hUP IFN4hUP
biological_process 5.84E-07 6.38E-06
signal transduction 3.62E-05 1.59E-04
response to stress 6.39E-05 1.37E-04
regulation of gene expression 2.27E-05 1.82E-03
regulation of apoptosis 8.12E-04 1.07E-03
cell communication 4.12E-05 5.65E-03
regulation of RNA metabolic process 8.79E-03 4.84E-03
regulation of transcription 7.87E-05 1.50E-02
regulation of transcription, 1.33E-02 9.08E-03
protein metabolic process 5.42E-02 2.34E-05
response to wounding 8.17E-04 6.57E-02
EGF24&48hUP IFN48hUP
biological_process 1.32E-02 3.32E-16
metabolic process 3.16E-02 8.99E-14
Gene ontology: Biological process EGF1&4hDN IFN4hDN
response to external stimulus 5.47E-04 1.79E-09
tissue development 6.50E-04 3.64E-05
cell differentiation 6.90E-04 5.94E-10
keratinocyte differentiation 1.42E-02 5.37E-04
epidermis development 8.64E-06 1.49E-02
response to chemical stimulus 2.22E-02 4.54E-08
defense response 2.05E-02 2.31E-03
response to stress 2.32E-02 2.67E-08
EGF24&48hDN IFN48hDN
response to stress 1.95E-06 9.50E-10
response to external stimulus 5.54E-04 4.70E-03
regulation of cell proliferation 2.87E-03 3.97E-03
biological_process 1.45E-02 3.66E-24
regulation of cell cycle 7.16E-02 1.01E-04
tissue development 7.13E-02 4.06E-02
b
Gene ontology: Biological process EGF1&4hUP IL1&1hUP
regulation of cell proliferation 1.65E-07 4.09E-08
biological_process 5.84E-07 3.75E-12
regulation of signal transduction 1.41E-07 2.34E-06
regulation of gene expression 2.27E-05 2.84E-12
signal transduction 3.62E-05 1.16E-06
cell communication 4.12E-05 4.90E-06
response to stress 6.39E-05 7.05E-11
regulation of transcription 7.87E-05 1.60E-12
regulation of cell motion 1.45E-07 9.43E-05
negative regulation of cell proliferation 5.55E-05 6.13E-05
Table 3 Biological processes common in the EGF-,
Interferon-γ- and IL-1-regulated genes (Continued)
negative regulation of prog. cell death 6.27E-04 5.05E-05
regulation of apoptosis 8.12E-04 3.33E-09
response to wounding 8.17E-04 7.63E-05
regulation of cell migration 6.33E-05 9.95E-04
positive regulation of chemotaxis 2.38E-04 1.68E-03
negative regulation of apoptos 3.07E-03 1.73E-04
positive regulation of signal 3.47E-03 1.15E-05
positive regulation of metabolism 4.70E-03 3.42E-08
positive regulation of cell process 1.64E-03 3.11E-03
regulation of RNA metabolic process 8.79E-03 1.06E-10
phosphate metabolic process 1.08E-02 1.26E-05
regulation of transcription, 1.33E-02 6.42E-11
response to external stimulus 2.35E-03 1.33E-02
regulation of transcription 1.59E-02 6.90E-10
transmembrane receptor protein 1.49E-02 1.59E-03
positive regulation of gene expression 3.33E-02 4.02E-06
positive regulation of cell motility 6.15E-04 3.31E-02
protein metabolic process 5.42E-02 1.31E-06
regulation of catalytic activity 7.77E-02 1.89E-08
transforming growth factor beta pathway 8.47E-02 6.35E-03
positive regulation of transcription 9.37E-02 1.88E-06
Gene ontology: Biological process EGF24&48hUP IL1&48hUP
biological_process 1.32E-02 8.89E-19
metabolic process 3.16E-02 1.32E-16
EGF1&4hDN IL1 1hDN
cell differentiation 6.90E-04 3.12E-03
epidermis development 8.64E-06 1.60E-02
keratinocyte differentiation 1.42E-02 3.78E-03
EGF24&48hDN IL1 48hDN
epidermis development 5.18E-03 6.21E-03
biological_process 1.45E-02 1.75E-14
response to stress 1.95E-06 3.26E-02
response to external stimulus 5.54E-04 4.08E-02
EGF1_4hUP EFNAs_DN
response to stress 6.39E-05 3.67E-02
EGF24_48hUP EFNAs_DN
biological_process 1.32E-02 6.92E-03
metabolic process 3.16E-02 3.29E-02
EGF1_4hUP RA4hDN
regulation of gene expression 2.27E-05 8.66E-05
regulation of transcription 7.87E-05 2.69E-04
cell communication 4.12E-05 2.62E-03
biological_process 5.84E-07 5.66E-03
signal transduction 3.62E-05 6.86E-03
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Table 4 Biological processes common in the EGF-,
EphrinAs- and SP600125-regulated genes
Gene ontology:
Biological process
EGF 1&4 h UP SP 1&4 h DN EFNAs DN
biological process 3.94E-07 9.37E-02 6.92E-03
signal transduction 1.65E-05 1.75E-03 1
cell communication 1.94E-05 4.39E-03 5.49E-01
response to stress 6.39E-05 1 3.67E-02
cell motion 3.70E-03 1 3.70E-02
EGF 1&4 h DN SP 1&4 h UP EFNAs UP




tissue development 6.50E-04 9.01E-02 1.52E-05








response to stress 2.32E-02 1.40E-07 1
EGF 24&48 h UP SP 1&4 h DN EFNAs DN
biological process 1.32E-02 9.37E-02 6.92E-03




blood coagulation 6.08E-02 3.59E-01 1
EGF 24&48 h DN SP 1&4 h UP EFNAs UP




regulation of cell proliferati 2.87E-03 4.68E-06 1
epidermis development 5.18E-03 1 9.39E-09
response to wounding 8.27E-03 2.60E-02 1




tissue development 7.13E-02 1 1.52E-05
regulation of apoptosis 8.77E-02 9.18E-01 1
UP denotes induced, DN suppressed genes. Note that the genes induced by
EGF are suppressed by EphrinAs and SP600125, and vice versa.
Table 3 Biological processes common in the EGF-,
Interferon-γ- and IL-1-regulated genes (Continued)
regulation of RNA metabolic process 8.79E-03 8.62E-05
regulation of cell migration 6.33E-05 1.03E-02
regulation of apoptosis 8.12E-04 1.01E-02
regulation of transcription 1.33E-02 1.88E-04
regulation of transcription 1.59E-02 6.81E-04
regulation of cell motion 1.45E-07 2.60E-02
regulation of cell proliferation 1.65E-07 4.18E-02
positive regulation of metabolism 4.70E-03 4.57E-02
regulation of signal transduction 1.41E-07 5.12E-02
EGF1_4hDN EFNAs_UP
epidermis development 8.64E-06 9.39E-09
tissue development 6.50E-04 1.52E-05
cell differentiation 6.90E-04 1.80E-07
keratinocyte differentiation 1.42E-02 1.58E-11
EGF24_48hDN EFNAs_UP
epidermis development 5.18E-03 9.39E-09
biological_process 1.45E-02 5.83E-04
tissue development 7.13E-02 1.52E-05
EGF1_4hUP RA4hUP
biological_process 5.84E-07 7.73E-05
regulation of gene expression 2.27E-05 1.05E-04
regulation of transcription 7.87E-05 2.86E-04
signal transduction 3.62E-05 3.42E-04
regulation of signal transduction 1.41E-07 4.46E-04
response to stress 6.39E-05 8.06E-04
negative regulation of program 6.27E-04 4.51E-04
cell communication 4.12E-05 2.77E-03
negative regulation of apoptosis 3.07E-03 3.61E-04
positive regulation of signal 3.47E-03 4.51E-04
phosphate metabolic process 1.08E-02 8.40E-05
regulation of RNA metabolic process 8.79E-03 4.78E-03
regulation of transcription, 1.33E-02 6.50E-03
regulation of transcription 1.59E-02 5.92E-03
positive regulation of metabolism 4.70E-03 1.99E-02
regulation of apoptosis 8.12E-04 4.33E-02
response to external stimulus 2.35E-03 4.24E-02
positive regulation of gene expression 3.33E-02 1.35E-02
protein metabolic process 5.42E-02 1.39E-03
positive regulation of transcription 9.37E-02 7.29E-03
a) The EGF and Interferon-γ overlaps b) The EGF and IL-1 overlaps. UP denotes
induced, DN suppressed genes. The numbers represent the p-values. While
many ontological categories are redundant, closely related or overly general,
note that keratinocyte differentiation is suppressed in all three sets, the EGF-,
Interferon-γ-, and IL-1-regulated genes. Also note that processes related to cell
motility are induced by EGF and IL-1, but not by IFNγ.
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AP1 protein binding sites were identified in the genes
regulated by both EGF and IL-1.
We also used Lists2Networks to identify the kinases
whose targets are overrepresented in the regulated genes
[43]. Using the KEA kinase targets analysis, we found
that both EGF and IFNγ induce targets of MAPK-1, -3






















EGF 24&48 h IL 1 24h
IL 1 48h
EGF 1&4 h
Figure 3 Overlapping kinase targets and transcription factor target genes. a) The kinases that target protein products of both the EGF and
the Interferon-γ regulated genes are shown on top. The transcription factors that target both the EGF and the Interferon-γ regulated genes are
shown on the bottom. b) Corresponding kinases and transcription factors for the EGF and IL-1 regulated overlapping targets. Black rounded
rectangles denote the kinases and transcription factors associated with multiple time points, gray ones those associated with a single time point.
The black rectangles on the right pertain to IFN-γ and IL-1 only, whereas those in the middle bestride the EGF and the IFN-γ/IL-1 sets.
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http://www.biomedcentral.com/1471-2164/14/85JAK-1 and −2. However, only ROCK1 targets are
induced already at 1 h, the targets for other kinases are
overrepresented in parallel at later times (Figure 3b).
EGF, IFNγ and IL-1 induce a similar family of kinase tar-
gets, but this induction occurs earlier in the IL-1-treated
cells than in the IFNγ-treated ones (Figure 3b). Despite
larger sets of common kinase targets induced by EGF
and IL-1, the set of transcription factors activated in
common by EGF and IL-1 is sparser – fewer AP1 pro-
teins were identified. We note, parenthetically, that the
kinases, and even more the transcription factors acti-
vated solely by IFNγ or by IL-1 (i.e., those not in com-
mon with the EGF-activated set) are very distinct. This
suggests that the effects of EGF overlap the distinct sub-
set of the effects of IFNγ and of IL-1.
Certain genes induced by EGF are suppressed by
EphrinAs, and vice versa (Figure 2). We reported that
EphrinAs induce keratinocyte differentiation markers
[38,44]; here we show that these markers are suppressed
by EGF. The antiparallel effects are evident at both early
and late time points (Table 4). SP600125 also induces
keratinocyte differentiation [40]; correspondingly, similarantiparallel effects are seen in the EGF- and SP600125-
treated keratinocytes (Table 4). Moreover, SP600125
induced inhibitors of proliferation, another effect anti-
parallel to EGF. Interestingly, the antiparallel effects of
EphrinAs and SP600125 are distinct and seem to
proceed via different mechanisms: of the kinases targets
induced by EGF, EphrinAs seem to suppress the targets
of MAPK-1, -3 and −14, while SP600125 none at all.
Conversely the targets of CDK1 and CDK2 suppressed
by EGF at late time point, seem induced by SP600125,
but not by EphrinAs (Table 5). Again, the effects of EGF
overlap the distinct effects of EphrinAs and of the JNK
inhibitor SP600125.
An interesting paradox emerges from the comparison
of genes regulated by EGF and by RA (Table 6). At the
earliest time point, 1 h after addition of RA, the effects
are largely antiparallel; for example, cell motility genes
are inhibited by RA, while EGF induces those (Table 6a).
At 4 h, both RA and EGF in parallel induce transcription
factors and signal transduction and in parallel suppress
apoptosis genes (Table 6b). Similar parallel effects are
maintained after 24 h, when cell adhesion and cell
Table 5 Kinases with common targets encoded by the
EGF-, EphrinAs- and SP600125-regulated genes
Kinase EGF 1&4 h UP SP 1&4 h DN EFNAs DN
MAPK1 2.51E-07 1 1.22E-02
SRC 5.21E-06 1 1
MAPK14 1.36E-05 1 1.88E-04
EGFR 1.39E-05 1 1
INSR 1.02E-04 1 1
MAPK3 1.70E-04 1 5.05E-02
JAK2 3.57E-04 1 1
ROCK1 2.62E-03 1 1
JAK1 3.30E-03 1 1
PTK2 3.62E-03 1 1
MAPK8 2.92E-02 1 1
PRKCQ 4.00E-02 1 1
ERBB2 5.35E-02 1 1
FYN 5.36E-02 1 1
JAK3 5.45E-02 1 1
IGF1R 7.63E-02 1 1
PRKCD 9.07E-02 1 1
EGF 24&48 h DN SP 24&48 h UP EFNAs UP
CDK2 5.84E-03 1.43E-04 1
CDC2 1.21E-02 2.45E-06 1
UP denotes induced, DN suppressed genes. All kinases with p-values better
than 0.1 for the EGF-regulated targets are listed. No kinases common to all
three agents were identified.






regulation of cell motion 1.45E-07 5.00E-06
regulation of cell proliferation 1.65E-07 3.06E-04
biological_process 5.84E-07 1.68E-03


















regulation of signal transduction 1.41E-07 4.46E-04
biological_process 5.84E-07 7.73E-05
regulation of gene expression 2.27E-05 1.05E-04
signal transduction 3.62E-05 3.42E-04
cell communication 4.12E-05 2.77E-03
response to stress 6.39E-05 8.06E-04




regulation of apoptosis 8.12E-04 4.33E-02
response to external stimulus 2.35E-03 4.24E-02
negative regulation of apoptosis 3.07E-03 3.61E-04






regulation of RNA metabolic
process
8.79E-03 4.78E-03
phosphate metabolic process 1.08E-02 8.40E-05
regulation of transcription 1.33E-02 6.50E-03










regulation of gene expression 2.27E-05 1.57E-02
signal transduction 3.62E-05 5.27E-04
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ingly, while MAPKs seem suppressed by RA after 1 h,
they appear activated after 4 h. Their activation is not
maintained at later time points, e.g., at 24 h, when tar-
gets of kinases EGFR, ErbB2 and Insulin receptor appear
specifically induced in the EGF treated keratinocytes
(Table 6c). The only transcription factors regulated by
both EGF and RA to a statistically significant level are
the NFκB proteins REL/RELA (Table 6d).
Metaanalysis, part 2: EGF effects in keratinocytes vs. EGF
effects in other cell types
EGF is a catholic regulator affecting many different cell
types. Curiously, transcriptional responses to EGF have
been described in several established cell lines, but not
in primary cultures. We compared our data with EGF-
regulated genes from 4 published studies, GSE6783,
GSE6784, GSE10778 and GSE13009 [13,14,45]. These
studies were selected because they compare directly
EGF-treated vs. untreated cells and, for ease of compari-
son, because they used Affymetrix microarrays.
Interestingly, we find that in epidermal keratinocytes,
as well as in HeLa and MCF10A cell lines, EGF regulates
many genes in parallel at the early time points, 1 and
Table 6 Biological processes common in the EGF- and
Retinoic acid-regulated genes (Continued)
cell communication 4.12E-05 1.41E-03
response to stress 6.39E-05 3.79E-04




regulation of apoptosis 8.12E-04 1.03E-04
response to wounding 8.17E-04 5.89E-04
response to external stimulus 2.35E-03 4.81E-03
regulation of cell adhesion 3.01E-03 3.76E-02
negative regulation of apoptosis 3.07E-03 2.99E-04
positive regulation of signal
transduction
3.47E-03 3.66E-02




phosphate metabolic process 1.08E-02 5.42E-02
protein metabolic process 5.42E-02 6.91E-03
EGF24&48hUP RA24hUP
cell differentiation 5.90E-05 1.23E-02
biological_process 1.32E-02 1.20E-08

















T. F. EGF1&4hUP RA4hUP RA24hUP
RELA 2.28E-03 3.99E-02 3.34E-02
REL 4.41E-03 4.19E-05 9.16E-02
The early EGF-induced genes have extensive overlaps with both induced and
suppressed genes by RA. a) Common processes in the EGF-induced and RA-
suppressed genes 1 h after RA treatment. b) Common processes in the EGF-
induced and RA-induced genes 4 h after RA treatment. c) Common kinase
targets in the products of EGF-induced and RA-regulated genes. d) Only the
NFkB family transcription factors have binding site overrepresented in both
the EGF-induced and RA-regulated genes.
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http://www.biomedcentral.com/1471-2164/14/854 hrs (Figure 4). While in keratinocytes there is a very
significant overlap between genes regulated at early and
at late time points (Figure 4 top), the parallel with HeLa
and MCF10A is clear for the induced genes only, not for
the suppressed ones. Similarly, the parallel between kera-
tinocytes and HUVEC holds for the induced genes only.
In contrast, MCF7 cell line shows transcriptional effects
antiparallel to those of keratinocytes, particularly at the
later time points, at 48 h.
We find important parallels in the biological processes
regulated by EGF in different cell types (Table 7). Specif-
ically, regulation of transcription is affected in all cell
types compared, at all time points (Table 7a). Similarly,
negative regulators of apoptosis are induced in all cell
types, although perhaps a little delayed in HUVEC
(Table 7e). On the other hand, regulation of cell motility,
signal transduction and cell proliferation are regulated in
all four epithelial cell types, but not in the endothelial
cells, HUVEC (Table 7b, c, d). Please also note that in
MCF7, transformed cells, the regulators of transcription
are downregulated at 48 hrs (marked with ! in Table 7).
Discussion
To define comprehensively the molecular effects of EGF
in human epidermal keratinocytes we used transcrip-
tional profiling and identified the regulated genes. WeCell type Gene sets EGF1&4hUP EGF1&4hDN
Epidermal EGF 1&4h UP Same 2.69E-01
keratinocyte EGF 1&4h DN 2.69E-01 Same
HeLa 1h UP 3.27E-48 2.31E-01
GSE6783 1h DN 2.78E-01 1.60E-03
4h UP 1.28E-55 5.17E-01
4h DN 1.92E-01 1.39E-07
MCF10A 1h UP 2.81E-36 2.71E-01
GSE6784 1h DN 1.93E-06 6.72E-05
4h UP 2.37E-43 4.30E-01
4h DN 5.40E-04 5.54E-11
HUVEC 1h UP 4.39E-24 3.45E-02
GSE10778 1h DN 2.39E-05 1.93E-02
6h UP 3.74E-20 2.76E-03
6h DN 1.38E-11 1.38E-01
MCF7 1h UP 6.87E-21 2.69E-03
GSE13009 1h DN 3.85E-05 1.98E-04
4h UP 5.06E-07 9.56E-04
4h DN 5.05E-11 4.02E-04
Late  EGF24&48hUP EGF24&48hDN
24h UP 7.79E-04 2.27E-09
24h DN 6.57E-08 1.27E-09
48h UP 3.02E-05 1.76E-13
48h DN 3.39E-11 9.86E-06
Figure 4 Overlaps of the lists of genes regulated by EGF in
keratinocytes with those regulated in other cell types. The
overlaps with p-values better than 10-10 are marked with gray.
Downward arrows mark strong overlaps in both the induced and
the suppressed gene lists. Upward arrows mark the antiparallel
overlaps, i.e., genes induced in keratinocytes, but suppressed in
MCF7 cells. The short arrows point to significant overlaps in the
induced genes only, but not in the suppressed ones.
Table 7 Biological processes common in keratinocytes and other cell types
Gene ontology process Keratinocytes HeLa MCF10A HUVEC MCF7
EGF1&4hUP GSE6783_1hUP 4 h UP GSE6784_1hUP 4 h UP GSE10778_1hUP 6 h UP GSE13009_1hUP 4 h UP 48 h DN (!)
a* regulation of
gene expression
2.27E-05 8.60E-07 5.40E-10 9.30E-07 7.98E-07 1.34E-07 1.4 -04 1.50E-12 2.22E-14 2.18E-04
regulation of transcription 7.87E-05 9.91E-08 2.90E-10 1.48E-06 3.52E-07 1.42E-09 4.1 -06 3.00E-11 1.71E-13 5.94E-05
regulation of RNA
metabolic process
8.79E-03 1.64E-05 3.38E-08 1.44E-04 8.88E-05 1.83E-06 3.7 -04 1.47E-09 1.83E-11 3.06E-03
regulation of transcription 1.33E-02 1.15E-04 2.32E-08 1.43E-04 9.91E-05 3.02E-07 8.1 -05 8.37E-09 1.32E-10 1.23E-03
regulation of transcription 1.59E-02 2.54E-05 1.99E-09 7.78E-04 1.41E-02 4.72E-06 4.6 -06 4.42E-06 6.28E-05 2.24E-03
positive regulation of
gene expression
3.33E-02 9.78E-01 4.61E-03 1.24E-04 6.09E-05 2.04E-04 1.6 -01 2.38E-02 2.64E-04 1.19E-01
positive regulation of
transcription
9.37E-02 6.97E-01 2.09E-03 1.51E-04 5.38E-05 2.25E-04 8.8 -02 2.47E-02 1.73E-04 7.71E-02
b regulation of signal
transduction
1.41E-07 3.63E-03 1.89E-03 6.60E-05 2.12E-04 1 1 9.89E-07 1.93E-04 1
signal transduction 3.62E-05 7.57E-02 6.05E-07 7.21E-11 4.10E-08 1 1 3.49E-10 4.23E-17 1
positive regulation of
signal trans.
3.47E-03 2.41E-01 3.57E-03 4.67E-03 6.83E-02 1 1 1.39E-01 6.02E-01 1
response to external
stimulus
2.35E-03 4.06E-01 1 8.03E-07 2.10E-01 1 1 1 1 1
negative regulation of
signaling
9.10E-05 1 1 1 8.38E-01 1 1 1 1 1
c regulation of cell motion 1.45E-07 2.89E-02 4.73E-04 1.24E-02 5.93E-04 1 1 3.63E-04 6.91E-03 5.47E-01
regulation of cell migration 6.33E-05 1.23E-02 6.66E-03 5.19E-02 1.44E-03 1 1 2.50E-04 3.01E-03 1
positive regulation of
cell motility
6.15E-04 2.41E-01 2.63E-02 6.38E-01 1 1 1 5.45E-03 7.82E-03 1
positive regulation of
chemotaxis
2.38E-04 9.30E-02 2.13E-03 1 1 1 1 5.00E-01 4.97E-02 1
positive regulation of cell
migration
4.30E-03 1.40E-01 9.60E-03 1 1 1 1 1.64E-03 1.73E-03 1
cell motion 3.70E-03 1.13E-01 7.39E-02 4.32E-01 2.75E-01 1 1 1 6.20E-01 1
d regulation of cell
proliferation
1.65E-07 6.74E-03 1.76E-03 2.75E-03 6.40E-02 1 1 8.19E-04 1.59E-03 1
positive regulation of cell
proliferation
1.64E-03 4.97E-02 9.70E-04 8.01E-03 1.51E-01 1 1 8.50E-03 4.71E-01 1
e negative regulation of
prog. cell death
6.27E-04 1.86E-02 1.25E-03 1.58E-04 2.33E-04 1 4.8 -01 5.84E-02 2.87E-03 1
regulation of apoptosis 8.12E-04 6.24E-02 8.43E-05 3.80E-07 2.73E-06 1 8.2 -02 4.64E-03 4.10E-05 1




























Table 7 Biological processes common in keratinocytes and other cell types (Continued)
negative regulation
of apoptos
positive regulation of metabolism 4.70E-03 4.24E-02 5.71E-04 2.01E-05 6.52E-09 1.68E-03 1 4.33E-04 4.40E-07 3.26E-03
regulation of catalytic activity 7.77E-02 6.24E-01 2.05E-04 2.31E-03 1.41E-06 1 1.41E-03 1.36E-04 2.64E-05 1
cell communication 4.12E-05 7.24E-02 2.42E-06 3.87E-11 9.10E-07 1 1 2.48E-09 1.97E-15 1
phosphate metabolic process 1.08E-02 4.54E-02 4.48E-06 1.12E-02 2.46E-04 1 1 5.72E-06 2.70E-06 1
response to stress 6.39E-05 8.57E-02 5.22E-02 2.15E-07 7.26E-07 3.42E-02 1 1 1 1
anatomical structure development 5.71E-02 1 2.87E-01 2.01E-02 1 1 1 1 5.53E-02 1
transforming growth factor
beta pathway
8.47E-02 1.19E-01 1 4.14E-01 1 4.44E-03 1 1 1 2.94E-01
positive regulation of leukocycytes 1.40E-02 1 5.51E-01 2.75E-01 1 1 1 9.41E-02 1 1
cell adhesion 8.83E-03 1 1 5.33E-04 1 1 1 1 1 1
transmembrane
receptor protein
1.49E-02 4.44E-01 1 8.14E-02 1 6.97E-02 1 1 1 1
response to wounding 8.17E-04 1 1 2.40E-05 2.37E-01 1 1 1 1 1
regulation of cell
adhesion
3.01E-03 1 1 7.25E-05 6.46E-02 1 1 1 1 1
negative regulation of
DNA binding
9.91E-02 1 1 1 1 1 1 1 1 3.53E-01
biological process 5.84E-07 1.83E-04 3.12E-14 3.61E-13 9.62E-15 6.34E-09 1.21E-07 1.43E-15 1.38E-21 3.52E-02
protein metabolic process 5.42E-02 1 1.54E-06 4.66E-04 6.72E-06 1.27E-06 8.12E-02 2.46E-05 5.42E-08 6.91E-01
EGF 24&48 h UP 48 h DN (!)
biological process 1.32E-02 1.83E-04 3.12E-14 3.61E-13 9.62E-15 6.34E-09 1.21E-07 1.43E-15 1.38E-21 1.08E-06
metabolic process 3.16E-02 1 4.33E-12 4.76E-05 2.73E-13 5.14E-15 6.13E-12 2.61E-05 2.83E-11 1.41E-07
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http://www.biomedcentral.com/1471-2164/14/85compared these with genes regulated in keratinocytes by
other extracellular signals, and with genes regulated by
EGF in other cell types. We found both expected and
unexpected classes of regulated genes. Because EGF reg-
ulates keratinocyte proliferation, the cell cycle genes
are prominently regulated, as expected; conversely, the
apoptotic signal genes are suppressed. Similarly, numer-
ous genes related to motility and substrate attachment
are induced by EGF, whereas those promoting rigid cell-
to-cell contacts are suppressed. As expected from such a
wide-ranging regulator, EGF induced many signalling
proteins, both intra- and extracellular. Unexpectedly,
EGF induced multiple members of the DUSP family; an
important function of the DUSPs is to attenuate and
dampen the signalling via ERKs, kinase members of the
EGF-responsive signalling cascades. Thus, EGF induces
its own feed-back mechanism, presumably to restrain
uncontrolled proliferation, motility etc. At the same
time, EGF induces production of HB-EGF and TGFα,
ligands of EGFR, which are expected to augment and ex-
tend the signalling. A similar incongruity is seen at the late
time points, 24 and 48 h, when both the cell cycle and
the apoptosis genes are suppressed by EGF. Apparently,
both positive and negative feedback are induced by EGF,
and which will prevail may depend on additional, EGF-
independent signals affecting the keratinocytes.
While keratinocytes in healthy epidermis divide in the
basal layer and differentiate as they move outward to the
surface of the skin, in wound healing and in various
pathological conditions keratinocytes become ‘activated’ –
they hyper-proliferate, migrate and elaborate complex de-
fence mechanisms to protect the tissues and the organism
beneath [46]. EGF is one such keratinocyte activating
signal and induces production of proinflammatory and
angiogenic cytokines and growth factors. Unexpectedly,
EGF suppresses the production of antibacterial defensins
and certain immunomodulators. Perhaps, then, the pri-
mary function of EGF in keratinocyte activation is in
wound healing and re-epithelialization, rather than in im-
mune responses and in fighting infection. We find that
some of the activation-associated subsets of genes are co-
regulated by EGF and IFNγ, some by EGF and IL-1 and
yet other gene subsets by all there. This reflects the dif-
ferent basic functions of proliferative, inflammatory and
immunomodulating cytokines and growth factors.
The regulation of keratinocyte differentiation markers
by EGF is complex: while the expression of one subset
of markers is suppressed, another subset is induced. Pro-
liferation and differentiation are incompatible: promot-
ing cell proliferation diverts the cells from differentiating
and consequently, certain differentiation markers are
suppressed by EGF. Unexpectedly however, lipid and
steroid biosynthesis enzymes are induced by EGF. Lipids,
including steroids, are essential for epidermal barrierfunction and are necessary for cornification, the final
stage of epidermal differentiation. Lipid biosynthesis
enzymes would not be expected to interfere with cell
proliferation, unlike e.g., large keratins or filaggrin, and
thus may not be incompatible with the proliferative
effects of EGF in keratinocytes. While both EGF and RA
generally inhibit keratinocyte differentiation, paradoxic-
ally, at the earliest time points many of the genes induced
by one are suppressed by the other and vice versa. Only
at later time points do EGF and RA regulate parallel sets
of genes. Conversely, SP600125 and EphrinAs promote
keratinocyte differentiation. However, the differentiation-
associated genes affected by SP600125 and those affected
by EphrinAs seem to be targets of different signalling
pathways. These results suggest that epidermal differenti-
ation is ‘modular’, not a fully integrated all-or-nothing
process; for example, while subsets of differentiation mar-
kers are suppressed by EGF, other subsets are induced.
Importantly, metaanalysis of EGF regulation in keratino-
cytes and other cell types shows important parallel and
antiparallel effects. Keratinocytes, HeLa and MCF10A
cells show the highest parallelism. All three are epithelial
and non-tumorigenic, and in these three cell types signal
transduction, proliferation, motility etc. are regulated in
parallel. In contrast, in HUVEC, which are not epithelial
but endothelial cells, motility, proliferation and signal
transduction are regulated differently. MCF7 cell line pre-
sents an interesting paradox: it is epithelial but also
tumorigenic, migratory and invasive. While some of the
early responses to EGF are parallel in MCF7 cells to those
in other epithelial cell types, at late time points they be-
come antiparallel – genes and processes induced by EGF
in keratinocytes, HeLa and MCF10A are suppressed in
MCF7, and vice versa. These conclusions agree with previ-
ous results demonstrating characteristic cytoskeleton
proteins, attachment and cell spreading in the MCF7
cells [47,48].
Conclusions
In conclusion, we present here a paradigm for systems
biology approach for integration of disparate sources of
transcriptional data. We used the effects of EGF in its
eponymous tissue, defined the transcriptional profile
changes and compared these with transcriptional profile
changes in the same cell type by different signalling, and
by the same signal in different cell type. The approach
can be widely generalized for similar studies.
Specifically, we find that EGF induces characteristic
aspects of keratinocyte activation, comprising prolifera-
tion and motility, but not activation of the immune re-
sponse. These aspects partially overlap the effects of
IFNγ and IL-1. At the same time, EGF suppresses cer-
tain aspects of keratinocyte differentiation, namely ex-
pression of many known differentiation markers, but not
Figure 5 Flowchart of analysis. The data flow from rectangle to
rectangle; the programs are named in bold italics and the analyses
to be performed by the investigator using spreadsheet are in ovals.
a) An example of large spreadsheets is given in Additional file 1:
Table S1. b) An example of Tables is given in Additional file 2: Table
S3, of Charts in Table 1 and of Clusters in Additional file 5: Table S2.
c) An example of Matrices is given in Figure 2, of Kinase Targets in
Table 5 and of Ontological Categories in common in Table 7.
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We conclude that both activation and differentiation of
keratinocytes are multifaceted, modular processes, rather
than all-or-nothing events, and that distinct, characteris-




The growth and treatment of keratinocytes has been
described [38,42,49]. Briefly, normal human neonatal fore-
skin epidermal keratinocytes were obtained from Dr. M.
Simon (Living Skin Bank, Burn Unit, State University of
New York, Stony Brook, NY) and grown in a defined
serum-free keratinocyte growth medium (Keratinocyte-
SFM, Invitrogen) supplemented with 2.5 ng/ml epidermal
growth factor, 0.05 mg/ml bovine pituitary extract, and
1% penicillin/streptomycin (keratinocyte growth medium)
at 37°C in 5% CO2 incubator. Generally, third passage
cells were used at 70–80% confluence. We changed the
medium to EGF-free and pituitary extract-free medium
24 h before the EGF treatment to starve the cells for EGF
and to avoid the effects of the supplements in growth
medium. Keratinocytes, grown on 100-mm plates, were
then treated with human EGF (20 ng/ml, Invitrogen) or
left untreated as controls. Parallel cultures of treated and
control cells were harvested by scraping 1, 4, 24 and 48 h
after treatment.
In our previous studies we used the same protocol for
the effects of Interferon-γ, Interleukin-1, and Ephrin As,
namely, the keratinocytes were pre-incubated in EGF-free,
pituitary extract-free medium for 24 h before the addi-
tion of these agents [38,41,42]. In our experiments using
SP600125 and retinoic acid we did not pre-incubate the
cells but added the drug directly to the complete medium,
i.e., containing both EGF and pituitary extract [39,40].
Cell count and the migration assay
Keratinocytes were grown on 12-well plates to 80% con-
fluency. The cells in un-supplemented medium were
treated with EGF, or left untreated as controls. After 24
and 48 h the cells were trypsinized and counted using a
hemocytometer. Three wells were measured at each time
point in each treatment. The error bars represent the
highest and lowest measured values.
Keratinocytes were grown on 12-well plates up to 80-
90% confluency as above, and treated with 8 μg/ml
mitomycin-C for 1 hour to prevent cells from dividing.
After washing, the keratinocyte monolayers were scratched
with a 200 μl pipette tip in each well to form a cross.
Then EGF (20 ng/ml) was added with the fresh medium.
Media were changed every 24 hours. At the 0, 24, and
48 h time points after the treatment, pictures were taken
under a microscope.Preparation of labelled cRNA and geneChip hybridization
We isolated total RNA from treated and untreated kerati-
nocytes using RNeasy kits (Qiagen) according to the
manufacturer’s instructions. Approximately 5 μg of total
RNA was reverse transcribed, amplified, and labelled as
described [49]. Fifteen micrograms of labelled cRNA was
fragmented and hybridized to HG-U95Av2 arrays
(Affymetrix). Arrays were washed, stained with anti-biotin
streptavidin-phycoerythrin-labelled antibody, and scanned
using the Agilent GeneArray scanner system (Hewlett-
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8 culture conditions.
Array data analysis
The flowchart of our analysis is presented in Figure 5.
Intensity values from the chips were obtained using
Microarray Suite version 5.0 (Affymetrix) and scaled by
calculating the overall signal for each array. Raw data
CEL files have been deposited in the Gene Expression
Omnibus (GEO) database (pending). To compare data
from multiple arrays, the signal of each probe array was
scaled to the same target intensity value. RMAExpress
[50] was used for background adjustment, quintile nor-
malization, summarization and quality analysis. Regulated
genes were selected as differentially expressed 50% or
more between the EGF-treated and the control samples at
the same time point. Annotation and ontology of the
regulated genes was obtained using the Database for An-
notation, Visualization and Integrated Discovery, DAVID
[24]. DAVID provided ‘tables’ containing functional and
ontological details of the regulated genes, ‘charts’ containing
ontological categories, pathways etc., over-represented in
the gene lists, ‘clusters’ of such ontological categories (which
identified redundancies and overlaps), transcription factors
over-represented in the promoters of the genes, as well as
sub-lists of genes specific for each ontological category.
Transcription factor binding sites were also evaluated using
DAVID, in a separate analysis.
Comparisons of regulated genes in keratinocytes
In our previous studies we defined the genes regulated in
keratinocytes by Interferon-γ, Interleukin-1, retinoic acid,
EphrinA proteins and JNK inhibitor SP600125 [38-42].
Using DAVID, we collected the lists of official symbols of
regulated genes in those studies, as well as of the EGF-
regulated genes from this study and submitted them to
the Lists2Networks analysis program [43]. The program
compares lists for mutual overlaps within specific categor-
ies, e.g., targets of protein kinases, ontological biological
process or OMIM disease gene association, returning statis-
tical evaluation of the overlaps. While we analyzed 7 differ-
ent relevant categories, we find ‘Gene Ontology Biological
Process’ to be the most informative, probably because it is
the best-annotated and most complete. We downloaded
the matrices of p-values of gene lists overlaps, as well as
spreadsheets of p-values of individual biological processes,
Bonferoni-corrected for multiple comparisons.
Metaanalysis of transcriptional responses to EGF in
various cell types
We searched GEO datasets and ArrayExpress using
“EGF” and “human” as keywords; then manually selected
the studies that directly compared EGF-treated vs. non-
treated samples. For simplicity of comparison, we limitedourselves to the studies using Affymetrix microarrays. For
four such studies we downloaded the CEL files and ana-
lyzed those using RMAExpress [50]. We then eliminated
the outlier chips, i.e., those with Normalized Unscaled
Standard Error medians 5% or more different from other
chips. This procedure provides a measure of relative chip
quality derived from the residuals from the RMA model
(for details see ref. [50]). After identifying the outliers, we
have re-run the RMAExpress program without the out-
liers. The EGF-regulated genes were selected as described
above. Lists of Affymetrix IDs of regulated genes were
submitted to DAVID [24]. From the tables provided from
DAVID analysis, we extracted lists of consensus gene
symbols, which we submitted to the Lists2Networks pro-
gram [43]. This allowed us to identify specific functional
commonalities in various lists of genes, providing the
metaanalysis results. Additional details of dataset search,
selection procedures and criteria, quality control, data for-
mats, ontological analyses and metaanalyses will be pub-
lished elsewhere (M.B. and C. Mimoso, in preparation).Additional files
Additional file 1: Table S1. EGF regulated genes. Expression levels are
given in Log2-transformed values. C denotes control, untreated, E the
EGF-treated samples. Red colour identifies genes induced by EGF 2-fold
or more, pink those induced 50% to 2-fold; bright green mark genes
suppressed 2-fold or more, light green those suppressed 50% to 2-fold.
We also show the maximum level of expression, and the maximum,
minimum and average levels of regulation. In the second spreadsheet of
the Additional file 1: Table S1 only the genes regulated at least 50% are
listed, the unselected genes are not.
Additional file 2: Table S3. EGF regulated genes in specific ontological
categories regulated by EGF at early time points, 1 and 4 h. a-f EGF
induced genes. g-k EGF suppressed genes. For details, please see the
main text. Note that many genes belong to multiple categories.
Additional file 3: Table S4. EGF regulated genes in ontological
categories regulated by EGF at late time points, 24 and 48 h. a-f EGF-
induced genes. g-i EGF-suppressed genes.
Additional file 4: Table S5. Numbers of genes in analyzed lists. These
lists were submitted to the Lists2Networks program. Results of analyses
are given in Figures 2 and 4, Tables 5 and 7.
Additional file 5: Table S2. Clustering of categories of EGF regulated
genes. DAVID algorithm identifies ontological and other categories that
have statistically significant overlaps of gene lists; this usually folds
redundant categories into easy-to-interpret clusters. Only clusters with
highest enrichment scores are presented, and in each cluster only the
top 2–3 categories. Count columns give the number of genes in each
category, % the percentage of submitted genes that belong to that
category, p-values the statistical value of each category (see e.g., Table 2
in the main text), while the enrichment score of a cluster gives the
statistical significance of the overlaps of gene lists.Competing interests
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